A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 8609466)

Published in J Gen Virol on May 01, 1996

Authors

P V Barnett1, L Pullen, R F Staple, L J Lee, R Butcher, D Parkinson, T R Doel

Author Affiliations

1: Institute for Animal Health, Pirbright Laboratory, Woking, Surrey, UK.

Articles by these authors

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol (1999) 10.86

A surgical approach to the cavernous portion of the carotid artery. Anatomical studies and case report. J Neurosurg (1965) 2.14

A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06

Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50

Effect of starvation on survival of three bacterial isolates from an arctic soil. Can J Microbiol (1978) 1.49

Traumatic intracranial aneurysms. J Neurosurg (1980) 1.44

Cloning and expression of the beta-D-phosphogalactoside galactohydrolase gene of Lactobacillus casei in Escherichia coli K-12. J Bacteriol (1982) 1.38

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabet Med (2008) 1.37

Arteriovenous malformations. Summary of 100 consecutive supratentorial cases. J Neurosurg (1980) 1.37

A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol (1991) 1.31

Foot-and-mouth disease: the risk for Great Britain after 1992. Vet Rec (1992) 1.25

Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24

Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. Arch Virol (1982) 1.23

MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology (1997) 1.22

A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22

Thermal stability of foot-and-mouth disease virus. Arch Virol (1981) 1.22

Cytotoxic T lymphocytes show HLA-C-restricted recognition of EBV-bearing cells and allorecognition of HLA class I molecules presenting self-peptides. J Immunol (1992) 1.21

Schwann cell development in embryonic mouse nerves. J Neurosci Res (1999) 1.21

Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology (1988) 1.20

Melanosis coli is associated with an increase in colonic epithelial apoptosis and not with laxative use. Histopathology (1997) 1.19

Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine (1990) 1.19

A study of self-esteem among well adolescents: seeking a new direction. Issues Compr Pediatr Nurs (1999) 1.17

Microsatellite flanking region similarities among different loci within insect species. Insect Mol Biol (2007) 1.13

Oxygen free radicals: in search of a unifying theory of disease. Intensive Crit Care Nurs (1995) 1.11

Moleculas aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses. J Gen Virol (1977) 1.10

The standardization of a 'spot-test' ELISA for the rapid screening of sera and hybridoma cell products II. The determination of binding capacity, binding ratio and coefficient of variation of different ELISA plates in sandwich and indirect ELISA. J Biol Stand (1984) 1.09

African-American physicians' views on health reform: results of a survey. J Natl Med Assoc (1994) 1.09

Transcavernous repair of carotid cavernous fistula. Case report. J Neurosurg (1967) 1.08

Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J Immunol (1998) 1.08

Preliminary studies on the development of a swine vesicular disease vaccine. Arch Gesamte Virusforsch (1974) 1.05

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. J Clin Oncol (1989) 1.04

A perspective on the clinical effectiveness and tolerance of interferon-alpha. Semin Oncol (1998) 1.03

Renal cell carcinoma: recent progress and future directions. Cancer Res (1997) 1.02

Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiol Infect (1993) 1.02

T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol (1989) 1.01

Analysis of human T cell response to two Plasmodium falciparum merozoite surface antigens. Eur J Immunol (1989) 1.00

Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report. J Clin Oncol (1994) 1.00

High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Immunology (1991) 0.99

Sympathetic connections to the fifth and sixth cranial nerves. Anat Rec (1978) 0.98

International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine (1996) 0.98

Carotid cavernous fistula: direct repair with preservation of the carotid artery. Technical note. J Neurosurg (1973) 0.98

Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA. J Immunol (1988) 0.97

The growth of a virulent strain of African swine fever virus in domestic pigs. J Hyg (Lond) (1968) 0.96

Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res (1998) 0.95

Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J Gen Virol (1990) 0.95

A comparative study of the spiritual perspectives and interventions of mental health and parish nurses. Issues Ment Health Nurs (2001) 0.95

MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology (1991) 0.94

Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inactivated preparations by the polymerase chain reaction. Vaccine (1993) 0.93

Synthesis, characterization and anticonvulsant activity of enaminones. Part 6: Synthesis of substituted vinylic benzamides as potential anticonvulsants. Bioorg Med Chem (1999) 0.93

Effects of a water-soluble extract of Cordyceps sinensis on steroidogenesis and capsular morphology of lipid droplets in cultured rat adrenocortical cells. J Cell Biochem (1998) 0.93

Lateral sellar compartment: history and anatomy. J Craniofac Surg (1995) 0.93

Studies on the pathogenesis of rinderpest in experimental cattle. IV. Proliferation of the virus following contact infection. J Hyg (Lond) (1965) 0.92

Immunohistochemical localization of choline acetyltransferase in the chicken mesencephalon. J Comp Neurol (1989) 0.92

Intracranial sympathetic pathways associated with the sixth cranial nerve. J Neurosurg (1974) 0.92

Biochemical aspects of variation in foot-and-mouth disease virus. J Gen Virol (1980) 0.91

Bernard, Mitchell, Horner syndrome and others? Surg Neurol (1979) 0.91

Low level lead exposure and neuropsychological functioning in blue collar males. Int J Neurosci (1987) 0.91

The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res (1996) 0.91

Descending noradrenergic pathways involved in the A5 depressor response. Brain Res (1986) 0.91

Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. J Environ Pathol Toxicol Oncol (1999) 0.90

Molecular imaging of slip in entangled DNA solution. Phys Rev Lett (2010) 0.89

Local recurrence after curative resection in patients with colon and rectal cancers. Int J Colorectal Dis (2008) 0.89

International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them. Vaccine (1990) 0.88

Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse. J Gen Virol (1998) 0.88

Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8. Arch Virol Suppl (1998) 0.88

Replacement laminotomy. Surg Neurol (1977) 0.87

Stability, continence and breathing: the role of fascia following pregnancy and delivery. J Bodyw Mov Ther (2008) 0.87

Persistent trigeminal artery: its relationship to the normal branches of the cavernous carotid. J Neurosurg (1974) 0.87

Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Arch Virol (1982) 0.87

African swine fever virus: a B cell-mitogenic virus in vivo and in vitro. J Gen Virol (1999) 0.87

Effects of light on dopamine metabolism in the chick retina. J Neurochem (1983) 0.87

Neurofibromatosis. Surg Neurol (1986) 0.87

EMA: a developmentally regulated cell-surface glycoprotein of CNS neurons that is concentrated at the leading edge of growth cones. Dev Dyn (1992) 0.86

Renal transport kinetics of furosemide in the isolated perfused rat kidney. J Pharmacokinet Biopharm (1986) 0.86

Dynamics of single polymers in a stagnation flow induced by electrokinetics. Phys Rev Lett (2004) 0.85

Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines. Vaccine (1991) 0.85

African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge. J Gen Virol (1997) 0.85

Expression of amyloid precursor protein in human astrocytes in vitro: isoform-specific increases following heat shock. Neuroscience (2000) 0.85

The function of synaptic transmitters in the retina. Annu Rev Neurosci (1989) 0.85

The standardization of a 'spot-test' ELISA for the rapid screening of sera and hybridoma cell products I. The determination of the optimum buffering system. J Biol Stand (1984) 0.84

A phase I trial of intravenous interleukin-6 in patients with advanced cancer. J Immunother Emphasis Tumor Immunol (1994) 0.84

Spontaneous subarachnoid hemorrhage first from an intracranial and then from a spinal arteriovenous malformation. Case report. J Neurosurg (1977) 0.83

An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cells. J Infect Dis (1990) 0.83

Self-esteem in adolescents treated in an outpatient mental health setting. Issues Compr Pediatr Nurs (1999) 0.83

Letter: Blood-lead levels, behaviour and intelligence. Lancet (1975) 0.83

Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice. J Biol Stand (1987) 0.83

The sinus of the dorsum sellae. Anat Rec (1985) 0.83

Challenges in companion animal welfare. J Small Anim Pract (2001) 0.82

Detection of β-amyloid peptide (1-16) and amyloid precursor protein (APP770) using spectroscopic ellipsometry and QCM techniques: a step forward towards Alzheimers disease diagnostics. Biosens Bioelectron (2010) 0.82

The biomechanics of concussion. Clin Neurosurg (1982) 0.82

An international collaborative study on foot and mouth disease virus assay methods. 2. Quantification of 146S particles. J Biol Stand (1985) 0.82

Increased fucosylation of glycolipids in a human leukaemia cell line (K562-Clone I) with decreased sensitivity to NK-mediated lysis. Immunology (1987) 0.81

Ossified epidural hematoma: case report. Neurosurgery (1980) 0.81

Evidence for a neurotransmitter role for 5-hydroxytryptamine in chick retina. J Neurosci (1981) 0.81

Magnolol stimulates steroidogenesis in rat adrenal cells. Br J Pharmacol (2000) 0.81

Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model. J Gen Virol (1991) 0.81

Further developments in the quantification of small RNA viruses by U.V. photometry of sucrose density gradients. Dev Biol Stand (1981) 0.81